XML 48 R38.htm IDEA: XBRL DOCUMENT v3.25.2
Net Loss Per Share - Computation (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Numerator:            
Net loss $ (21,126) $ (19,658) $ (16,943) $ (15,520) $ (40,784) $ (32,463)
Net loss attributable to noncontrolling interest 2   12   12 43
Net loss attributable to Barinthus Biotherapeutics plc shareholders $ (21,124)   $ (16,931)   $ (40,772) $ (32,420)
Denominator:            
Weighted-average ordinary shares outstanding, basic (in shares) 40,343,521   39,041,111   40,304,584 38,907,296
Weighted-average ordinary shares outstanding, diluted (in shares) 40,343,521   39,041,111   40,304,584 38,907,296
Net loss per share attributable to ordinary shareholders, basic (in usd per share) $ (0.52)   $ (0.43)   $ (1.01) $ (0.83)
Net loss per share attributable to ordinary shareholders, diluted (in usd per share) $ (0.52)   $ (0.43)   $ (1.01) $ (0.83)